Your browser doesn't support javascript.
loading
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
Wu, Dan; Ye, Ying; Tang, Lin; Wang, Ai-Bin; Zhang, Rui; Qian, Zhao-Hui; Wang, Fu-Zhen; Zheng, Hui; Huang, Chang; Lv, Xiao-Ya; Wang, Hai-Feng; Zhang, Yan-Yang; Pan, Jing-Jing; Li, Ya-Fei; Lu, Ming-Xia; Wang, Chang-Shuang; Ma, Ya-Ting; An, Zhi-Jie; Rodewald, Lance Everett; Yin, Zun-Dong; Wang, Xuan-Yi; Wu, Zhi-Yin; Shao, Yi-Ming.
Afiliação
  • Wu D; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Ye Y; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Tang L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Wang AB; Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Zhang R; National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • Qian ZH; NHC Key laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang FZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Zheng H; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Huang C; Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Lv XY; Nanning Center for Disease Control and Prevention, Guangxi, People's Republic of China.
  • Wang HF; Development Center for Medicine and Science &Technology, National Health Commission, People's Republic of China, Beijing.
  • Zhang YY; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Pan JJ; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Li YF; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Lu MX; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Wang CS; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Ma YT; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • An ZJ; Henan Provincial Disease Control and Prevention, People's Republic of China, Henan.
  • Rodewald LE; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Yin ZD; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Wang XY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Wu ZY; Key Laboratory of Medical Molecular Virology of MoE & MoH, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, People's Republic of China.
  • Shao YM; Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 1950-1958, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35850623
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article